daptomycin vs ezetimibe

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of daptomycin and ezetimibe. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

moderate Known Drug Interaction

Daptomycin Clinical Impact: Cases of rhabdomyolysis have been reported with simvastatin administered with daptomycin. Both ezetimibe and simvastatin and daptomycin can cause myopathy and rhabdomyolysis when given alone and the risk of myopathy and rhabdomyolysis may be increased by coadministration. Intervention: If treatment with daptomycin is required, consider temporarily suspending ezetimibe and simvastatin during the course of daptomycin treatment.

Drug Class
daptomycin Lipopeptide Antibiotic
ezetimibe Cholesterol Absorption Inhibitor
Type
daptomycin Prescription
ezetimibe Prescription
Summary
daptomycin

Daptomycin is an antibiotic medicine. It fights certain bacterial infections in your body.

ezetimibe

No summary available.

What It Treats
daptomycin

Daptomycin treats complicated skin infections in adults and children ages 1-17. It also treats Staphylococcus aureus bloodstream infections (bacteremia) in adults and children ages 1-17. Daptomycin is not used to treat pneumonia or left-sided heart infections.

ezetimibe

Information not available.

How It Works
daptomycin

Daptomycin works by attaching to the cell membrane of bacteria. This causes the bacterial cell membrane to become unstable. The instability stops the bacteria from growing, eventually killing it.

ezetimibe

Information not available.

Common Side Effects
daptomycin
  • Diarrhea
  • Headache
  • Dizziness
  • Rash
  • Abnormal liver tests
ezetimibe
  • Headache
  • Upper respiratory tract infection
  • Muscle pain
  • Diarrhea
FAERS Reports
daptomycin
  • Acute Kidney Injury 527
  • Pyrexia 459
  • Eosinophilic Pneumonia 418
  • Rhabdomyolysis 336
  • Eosinophilia 328
ezetimibe
  • Fatigue 4,663
  • Nausea 4,195
  • Myalgia 4,191
  • Diarrhoea 3,662
  • Dizziness 3,338
Serious Warnings
daptomycin

Daptomycin can cause serious side effects. It can cause allergic reactions, muscle problems (myopathy and rhabdomyolysis), and a type of pneumonia (eosinophilic pneumonia). It can also cause severe skin reactions, kidney problems, nerve damage, and diarrhea from C. difficile. Tell your doctor right away if you have any of these side effects.

ezetimibe

No specific warnings noted.

Pregnancy
daptomycin

Tell your doctor if you are pregnant or breastfeeding. There is limited information about daptomycin use during pregnancy. Daptomycin does pass into breast milk in small amounts, but the effects on the baby are unknown.

ezetimibe

No pregnancy information available.

How to Read This daptomycin vs ezetimibe Comparison

daptomycin is classified in the Lipopeptide Antibiotic drug class, while ezetimibe sits within the Cholesterol Absorption Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, daptomycin has 2,068 submissions while ezetimibe has 20,049. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to both of these medicines can cause muscle damage as a side effect. taking them together makes this risk even higher and can lead to a serious condition where muscle tissue breaks down.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for daptomycin or ezetimibe.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.